Skip to content
Open access

Data driven selection of consensus docking pipelines for structure based hit identification

Sep 2026 · npj Drug Discovery · Vol 3 · 0 citations · 89 references
Medicine

TL;DR

MolDockLab addresses the challenge of structure-based virtual screening with an automated, data-driven framework that optimizes SBVS workflows for a protein target, balancing predictive performance and computational efficiency.

Abstract

Structure-based virtual screening (SBVS) is a cornerstone of computer-aided drug design, yet its success depends on selecting a combination of docking tools, scoring function (SF), and ranking strategies. MolDockLab addresses this challenge with an automated, data-driven framework that optimizes SBVS workflows for a protein target, balancing predictive performance and computational efficiency. It systematically explores combinations of five docking engines, 15 SF, and three consensus ranking strategies using a calibration set of ≈ 200 compounds with known bioactivity, and applies the best-correlating workflow to the larger screening library. Final hit selection from the top 1% integrates protein-ligand interaction profiler (PLIP)-derived interaction fingerprints, structural-diversity assessment, and expert visual inspection. In a retrospective evaluation on the epidermal growth factor receptor (EGFR), the chosen pipeline achieved a Spearman correlation of 0.36 and an enrichment factor (EF) at 10% of 1.57, consistent with calibration. Prospectively, for the energy coupling factor transporters (ECF-T)-a challenging transmembrane target with a cryptic binding site and no co-crystallized ligand-the pipeline reached a correlation of 0.45 and enrichment of 3.13. Post-processing enabled in vitro confirmation of two chemically novel inhibitors rivaling the most potent ECF-T inhibitors reported to date.

Read PDF

Similar papers

Open access Sep 2026

DockM8: an all-in-one open-source platform for consensus virtual screening in drug design

Virtual screening remains a critical step in structure-based drug design, yet variability in docking algorithms and scoring functions often limits its reliability. To address this challenge, we introduce DockM8, an open-source platform for consensus virtual screening that integrates pocket detection, ligand preparation...

Antoine Lacour, Hamza Agha, Anna K. H. Hirsch et al. · 4 citations
Oct 2026

Diversity-Seeking Docking-Guided Molecular Design Discovers Broader Predicted Interaction Profiles across Protein Families

Structure-based discovery pipelines commonly prioritize a scalar docking score, concentrating candidates into narrow chemotypes and contact patterns. We formulate docking-guided de novo molecular design as a diversity-seeking exploration problem and compare goal-directed, quality-diversity, Pareto-optimization, affin...

Zacharie Bugaud · 0 citations
Sep 2026

Performances and Critical Limitations of Docking and Protein–Ligand Interactions for Efficacy-Driven Virtual Screening Targeting Class A GPCRs

A comprehensive assessment based on systematic benchmarking using a diverse set of class A G-protein-coupled receptors and different approaches to represent protein–ligand demonstrates that the combined approach overall improves the efficacy bias of selected ligands as compared to docking alone.

Luca Chiesa, G. Bret, Severine Schneider et al. · 0 citations
Open access Sep 2026

Docking-score landscapes shape active-learning performance across Vina, Glide, and SILCS

This study compares four active-learning virtual screening workflows and suggests that combining active learning with SILCS provides a computationally efficient, membrane-aware approach for screening compounds at transmembrane binding sites.

Joseph Chung, Aashish Bhatt, Jacob Ede Levine et al. · 0 citations
Review Sep 2026

Exploring Optimal Parameters for Ligand-Based Virtual Screening in Early Drug Discovery

The results support a staged screening design in which a pooled default is followed by ligand-specific calibration and expert review, and SCScore showed the highest association with the blinded consensus, but performance varied by ligand.

T. Sobodu, Victor Chibuzor Johnson, Ryan Kern et al. · 0 citations
Open access Sep 2026

AI Accelerated Chemical Screening Integrates ChemBERTa to Identify Repositionable CASP4 Inhibitors via MD Simulations and MM/PBSA Analysis

This study employed an integrated ligand-based virtual screening pipeline to identify potential CASP4 inhibitors from the DrugBank database, leveraging docking-score prioritization, SMILES-derived ChemBERTa embeddings, and key physicochemical descriptors to systematically prioritize repurposed DrugBank compounds for CA...

Mubashir Hassan, S. Bhatti, Muhammad Yasir et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.